Review Process
Projects will be assessed on: strength of rationale; quality of science; un-met medical need; future commercial opportunity and clinical implementation into LMIC settings; IP position; likelihood of developing a full proposal to be submitted to external translational award schemes, or similar follow-on funding schemes, within the required timescale and budget. Should ethics and/or home office approvals be required for the projects, priority will be given to those applications that already have these in place.
Applications will be reviewed by the MORU-Oxford DiTi Panel in mid-October and a funding decision will be made. Award letters will be sent out by 31st October.
Please note, the MORU-Oxford DiTi Panel membership comprises both internal academic and external commercial experts to ensure robust, vigorous review in line with funder recommendations. All external members are required to sign a CDA prior to reviewing applications. Find further further information on Panel membership.